The Child Neurology Society received word today of the death on April 9, 2015 of Richard J. Allen, MD at the age of 91.  Dr. Allen hosted the first Child Neurology Society meeting in Ann Arbor in 1972.  He served as its first Secretary-Treasurer and, then, as its fifth President.  An NIH-funded investigator, he is perhaps best known for design and establishment as standard of practice a method for diagnosis and management of PKU, galactosemia, maple syrup urine disease, and biotinidase deficiency in newborn infants.  Dr. Allen obtained his B.S., M.S., and M.D. degrees from the University of Michigan, where he also pursued his post-doctoral clinical training in Pediatrics and Neurology.  He completed an NIH-funded fellowship in Pediatric Neurology at Columbia Presbyterian's Neurological Institute.  A prolific and sought-after lecturer, author, and clinician, Dr. Allen was honorably discharged as a proud captain in the U.S. Air Force in 1954.  He published his first peer-reviewed paper on para-aminosalycylic acid in 1951 and his last on epimerase deficiency galactosemia in 1998.  At the time of his death, he was Professor Emeritus of Pediatrics and Neurology at the University of Michigan.  Our condolences to Dr. Allen's wife, Bettye, and son, Tom, both of Ann Arbor, and daughter, Wendy, and grandchildren in Colorado, and to all of his colleagues and trainees through whom his legacy will live on.

Nina F. Schor, MD, PhD
President, Child Neurology Society